发明名称 Adenoviral vectors modified for increased and persistent expression of the cystic fibrosis transmembrane conductance regulator gene in human airway epithelia
摘要 Disclosed are recombinant viral vectors for gene transfer to the epithelium of patients. Preferred embodiments include adenoviral vectors designed for the efficient transfer of the DNA encoding the cystic fibrosis transmembrane conductance regulator (CFTR) to human airways <i>in vivo</i>. The present invention provides vectors for the enhanced expression and persistence of a gene such as CFTR, which may allow lower vector doses and/or longer intervals between readministration and which comprise, in operable linkage, the keratin 18 (K18) promoter/enhanier element, an intron, the transgene and a stability enhancing element.
申请公布号 AU7085500(A) 申请公布日期 2001.04.10
申请号 AU20000070855 申请日期 2000.08.29
申请人 GENZYME CORPORATION 发明人 HELEN ROMANCZUK;SAMUEL C WADSWORTH;RICHARD J GREGORY
分类号 A61K38/17;A61K48/00;C12N15/861 主分类号 A61K38/17
代理机构 代理人
主权项
地址